• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 1997

View Archived Issues

Orally active antithrombotic agents described by Pfizer

Read More

Improved dolastatin derivatives prepared by BASF

Read More

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

Read More

Thrombin inhibitors from Akzo Nobel

Read More

MS&D reports another series of potent and selective 5-HT1D agonists

Read More

Hoechst reveals new Na+/H+ exchange inhibitors

Read More

Kyowa Hakko discloses new calcitonin derivatives

Read More

Novel semisynthetic macrolides from Abbott

Read More

SKB discovers first selective human 5-HT1B receptor ligand

Read More

Novel anxiolytic and antidepressant buspirone analogue characterized

Read More

MDR-reversing agent from Mitsui Toatsu characterized in vitro and in vivo

Read More

FDA approves Hemagen Diagnostics' test for primary biliary cirrhosis

Read More

Cytel and Baxter enter research agreement for the development of ex vivo cancer therapy

Read More

Preclinical profile of MDL-27192

Read More

OrthoLogic and Sanofi to market sodium hyaluronate for osteoarthritis knee pain in the U.S.

Read More

Update on new injectable streptogramin antibiotic

Read More

Phase II results with Immunex's Flt3 ligand reported

Read More

NDA for entacapone scheduled for submission this month

Read More

Seikagaku's SOD preparation enters clinic in Europe

Read More

BMS to comarket antiemetic azasetron in Japan

Read More

More news on resveratrol

Read More

Lidak reports promising phase I/II data with melanoma vaccine

Read More

Baxter's DCLHb safe in acute ischemic stroke patients

Read More

Cambridge NeuroScience suspends phase III trial of Cerestat following interim data analysis

Read More

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

Read More

PEG-rHuMGDF enhances platelet recovery in cancer patients undergoing chemotherapy

Read More

Advisory committee recommends Taxol for KS

Read More

Agouron's acquisition of Alanex final

Read More

Meridian and Genpharm sign marketing agreement

Read More

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

Read More

IDEC and SmithKline Beecham suspend rheumatoid arthritis trial

Read More

New indication for enoxaparin recommended for approval

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe